Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

MK-6158: sGC stimulator clinical candidate for pulmonary arterial hypertension

March 28, 2022

German researchers divulge nitric oxide production inhibitors

March 25, 2022

New rat model may shed light on mechanisms behind CSVD pathogenesis

March 17, 2022

Cybin IRL describes new 5-HT2 receptor agonists

March 15, 2022

Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists

March 14, 2022

Medshine Discovery discloses new S1PR1 agonists

March 11, 2022

Bristol Myers Squibb describes FPR2 and FPR1 agonists

March 8, 2022

Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical

Feb. 24, 2022

Novel target identified for long QT

Feb. 23, 2022

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Feb. 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.